Format

Send to

Choose Destination
J Diabetes Sci Technol. 2018 Sep 21:1932296818803588. doi: 10.1177/1932296818803588. [Epub ahead of print]

Artificial Pancreas Systems for People With Type 2 Diabetes: Conception and Design of the European CLOSE Project.

Author information

1
1 Profil, Neuss, Germany.
2
2 Department of Pediatrics, Oncology, Hematology and Diabetology Łódź, Medical University of Łódź, Poland.
3
3 aQua-Institute for Applied Quality Improvement and Research in Health Care, Goettingen, Germany.
4
4 Clinical and Experimental Endocrinology, Catholic University of Leuven, Leuven, Belgium.
5
5 IESE Business School, University of Navarra, Barcelona, Spain.
6
6 Air Liquide Santé International, Gentilly, France.
7
7 Sanofi, Frankfurt/Main, Germany.
8
8 EIT Health, Munich, Germany.
9
9 EIT Health Germany, Mannheim/Heidelberg, Germany.
10
10 EIT Health InnoStars, Budapest, Hungary.
11
11 Department of Internal Medicine and Diabetology, Medical University of Łódź, Łódź, Poland.
12
12 Montpellier University Hospital, Department of Endocrinology, Diabetes, Nutrition, and Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France.

Abstract

In the last 10 years tremendous progress has been made in the development of artificial pancreas (AP) systems for people with type 1 diabetes (T1D). The pan-European consortium CLOSE (Automated Glu cose Contro l at H ome for People with Chronic Disea se) is aiming to develop integrated AP solutions (APplus) tailored to the needs of people with type 2 diabetes (T2D). APplus comprises a product and service package complementing the AP system by obligatory training as well as home visits and telemedical consultations on demand. Outcome predictors and performance indicators shall help to identify people who could benefit most from AP usage and facilitate the measurement of AP impact in diabetes care. In a first step CLOSE will establish a scalable APplus model case working at the interface between patients, homecare service providers, and payers in France. CLOSE will then scale up APplus by pursuing geographic distribution, targeting additional audiences, and enhancing AP functionalities and interconnectedness. By being part of the European Institute of Innovation and Technology (EIT) Health public-private partnership, CLOSE is committed to the EIT "knowledge triangle" pursuing the integrated advancement of technology, education, and business creation. Putting stakeholders, education, and impact into the center of APplus advancement is considered key for achieving wide AP use in T2D care.

KEYWORDS:

France; closed-loop; digital health; education; homecare; public-private partnership

PMID:
30241444
DOI:
10.1177/1932296818803588

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center